Abbratech has leased a 5,000-square-foot space for research and development at 25 Business Park Drive, Branford.
Founded in 2020, the company is working to apply knowledge from the past 15 years of human genome sequencing and Ab (antibody) engineering to produce recombinant Abs. The company says its technological advances allow it to make antibodies with targeted precision.